MSK physicians collaborate with hospitals and physicians from around the world on virtual tumor board events to deepen our understanding of cancer and to discuss effective and innovative approaches for treatments.
VIDEO | 02:54:29
Two of today’s most challenging aspects of oncology are interpreting results from next-generation genomic sequencing and identifying the right drug for the right patient. Join global oncology experts from MSK and M | O | C Cancer Care & Research for an insightful discussion on how molecular profiling is transforming breast cancer treatment.
VIDEO | 02:16:51
Interpreting diagnostic results and developing optimal treatment plans for invasive lobular breast cancer can be challenging. Join global oncology experts from MSK and Bharatiya Medical College for an insightful presentation on the complexities of diagnosing and treating this unique subtype of breast cancer.
VIDEO | 01:59:39
Dr. Jasmeet C. Singh (MSK, NY), Dr. Andrew D. Seidman (MSK, NY) facilitates a discussion with experts from MSK and Max Healthcare (India) about the unique clinical scenarios, challenges, and global perspectives associated with metaplastic breast cancer.
Gynecological cancers are the leading causes of cancer morbidity and mortality for women in India. Doctors from MSK in New York partnered with doctors from RCC, Thiruvananthapuram to present two mucinous ovarian neoplasms cases as part of an ongoing multidisciplinary tumor board series.
Unraveling the Challenges: Comprehensive Approach to Management of Oligoprogression in Breast Cancer
Dr. Jasmeet C. Singh (MSK, NY), Dr. Andrew D. Seidman (MSK, NY) and Dr. Atul Batra (AIIMS, India) moderate a discussion with their fellow world-renowned colleagues about the management of oligoprogression in breast cancer.
Join leading global experts to discover best practices on interpreting results from next-generation genomic sequencing of cancer, and identifying the right drug for the right patient.
The second in an ongoing series led by Dr. Mrinal Gounder of MSK and Dr. Sewanti Limaye of Sir HN Reliance Foundation Hospital in Mumbai, this tumor board focused on the BRAF pathway.
Gynecological cancers are the leading causes of cancer morbidity and mortality for women in India. To share expertise, advance research, and improve patient outcomes, Memorial Sloan Kettering Cancer Center (MSK) in New York is excited to present an educational series between MSK and the leading institutions of India. For this particular event, we are honored to partner with CMC Vellore in India.
Partnering with Apollo Hospital in Mumbai, India the multidisciplinary tumor board on May 19 included presentations on margin assessment, along with case studies on management of early oral cancer as well as locally advanced oral cancer.
